Ranbaxy, Teva, Mylan Launch Generic Actos, Will Share 180-Day Exclusivity

Drug Industry Daily
A A
Ranbaxy, Teva and Mylan launched generic versions of Takeda’s Type 2 diabetes drug Actos Friday, nearly four years before Takeda loses exclusivity.

To View This Article:

Login

Subscribe To Drug Industry Daily